Skip to main navigation Skip to search Skip to main content

Migration Stimulating Factor (MSF) promotes fibroblast migration by inhibiting AKT

    Research output: Contribution to journalArticlepeer-review

    Abstract

    The protein kinase AKT is activated strongly by many motogenic growth factors, yet has recently been shown capable of inhibiting migration in several cell types. Here we report that treatment with Migration Stimulating Factor (MSF), a truncated form of fibronectin that promotes the migration of many cell types, inhibits Ala activity in human fibroblasts and endothelial cells. In fibroblasts, treatment with either MSF or the AKT inhibitor, Akti-1/2, stimulated migration into 3D collagen gels to a similar extent and the effects of Akti-1/2 on migration could be blocked by the expression of an inhibitor-resistant mutant, AKT1 W80A. These data indicate that MSF promotes fibroblast migration, at least in part, by inhibiting the activity of AKT. (C) 2010 Elsevier Inc. All rights reserved.

    Original languageEnglish
    Pages (from-to)1655-1659
    Number of pages5
    JournalCellular Signalling
    Volume22
    Issue number11
    DOIs
    Publication statusPublished - Nov 2010

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • AKT
    • MSF
    • Kinase
    • Cell migration
    • Phosphoinositide 3-kinase
    • PROTEIN-KINASE B/AKT
    • CELL-MIGRATION
    • ENDOTHELIAL-CELLS
    • EGF RECEPTOR
    • IN-VITRO
    • CHEMOTAXIS
    • INSULIN
    • CANCER
    • FIBRONECTIN
    • INVASION

    Fingerprint

    Dive into the research topics of 'Migration Stimulating Factor (MSF) promotes fibroblast migration by inhibiting AKT'. Together they form a unique fingerprint.

    Cite this